Tramadol, buy tramadol, antibiotics, Weight Loss drugs, weight loss herbs, weight loss herbal formula, weight loss, hair loss, hair growth, hair regrowth, hair restoration, baldness, Rx Online, pharmaceuticals, DHEA, Lutein, Prescription, Prescription drug, prescription medications, Propecia.

References: Hair growth and hair loss

tinet.fut.es

BACKGROUND: A relatively inexpensive, portable epilation system based on unfiltered flashlamp technology (Spa Touch, Epilast, Paris, France)was macroscopically and histologically evaluated for efficacy and duration of hair removal. PATIENTS AND METHODS: Ten patients participated (eight female, two male, aged 22-62 years, skin types I-V). The system delivers a 35 ms pulse of 6-7.5 J/cm2 of broadband infrared visible light through a large treatment window in the handpiece, held in light contact with the target skin,without skin cooling or anaesthesia.The skin was shaved before the first treatment, and the subsequent frequency of application over a further four sessions was done every month. RESULTS: Histology revealed the destruction of most of the hair shaft, with regrowth of finer and lighter hair approximately 4 weeks after the final treatment, depending on the area treated. Patients were satisfied with results if epilation was maintained on a monthly basis. A delay in treatment allows hair to grow back. An interesting observation was recorded on white and vellous hair. Nine of the 10 patients noted better skin condition in the treated area. CONCLUSIONS: This system retards hair regrowth and acts as a 'light razor' that can be implemented for speedy epilation at a reasonable cost.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12745595&dopt=Abstract

Australas J Dermatol. 2003 May;44(2):106-9.
PUVA treatment of alopecia areata totalis and universalis: a retrospective study.

Whitmont KJ, Cooper AJ.

Royal North Shore Hospital, Pacific Highway, St Leonards, New South Wales, Australia.

The results of PUVA treatment of alopecia areata (AA) totalis and universalis were reviewed in 26 adult patients. Eight of 15 patients with AA totalis and six of 11 patients with AA universalis achieved a complete response (>90% hair regrowth). Patients with AA totalis had a greater incidence of treatment failure (<25% hair regrowth) than those with AA universalis. Patients with a family history of AA were significantly less likely to have a positive response to PUVA than those with no family history. Sex, age at diagnosis and treatment, interval between diagnosis and treatment, and background of atopy were not significant determinants of outcome. Although unable to show significance for clinical response to treatment, this study demonstrates complete hair regrowth in patients with both AA totalis (53%) and universalis (55%) while reporting a low relapse rate among these patients (21%) within a long period of follow up (mean 5.2 years).

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12752182&dopt=Abstract

nemours.org

OBJECTIVE: To discuss the factors associated with hair loss reported after the completion of extracorporeal membrane oxygenation. DESIGN: Prospective survey and retrospective chart review. SETTING: Tertiary care pediatric and adult extracorporeal membrane oxygenation program in a children's hospital. PATIENTS: All patients aged > or =60 months who underwent extracorporeal membrane oxygenation for respiratory or cardiac failure. INTERVENTIONS: Telephone survey of all patients or patient families who met study entry criteria. MEASUREMENTS AND MAIN RESULTS: Twelve extracorporeal membrane oxygenation patients met entry criteria. Nine were contacted and surveyed. Seven children and one adult reported hair loss. One child had no reported hair loss. One patient had a reported hair loss of <10%, three had 25% hair loss, two had 50% hair loss, and two had >50% hair loss. Initial hair loss occurred between 2 wks and 3 months after extracorporeal membrane oxygenation and lasted from 1 to 6 months. No patient sought medical treatment and all reported regrowth of their hair by 6 months after identifying the initial hair loss. CONCLUSIONS: Hair loss after critical illness is a well-documented phenomenon. Hair loss after extracorporeal membrane oxygenation has not been previously reported. The etiology of the hair loss is probably multifactorial and resolves spontaneously. Patients and families should be educated about hair loss as a potential side effect of extracorporeal membrane oxygenation during their post-extracorporeal membrane oxygenation and discharge teaching.

online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12831421&dopt=Abstract

Lipitor

Herbs and Pharmaceuticals Online || Hair Million herbal formula for hair loss and hair growth || Hair growth research references || E-Mail Us